Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders Growth (5y) (2015 - 2026)
Catalyst Pharmaceuticals (CPRX) Net Income towards Common Stockholders Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
| 10 |
Catalyst Pharmaceuticals |
3.84 Bn |
3.08 Bn |
134.92 Mn |
| Date | Value |
|---|
| Mar 31, 2026 |
52.75% |
| Dec 31, 2025 |
32.06% |
| Sep 30, 2025 |
4.02% |
| Jun 30, 2025 |
39.74% |
| Mar 31, 2025 |
40.33% |
| Dec 31, 2024 |
42.43% |
| Sep 30, 2024 |
26.35% |
| Jun 30, 2024 |
30.06% |
| Mar 31, 2024 |
107.12% |
| Dec 31, 2023 |
25.99% |
| Sep 30, 2023 |
-31.45% |
| Jun 30, 2023 |
52.80% |
| Mar 31, 2023 |
48.36% |
| Dec 31, 2022 |
52.90% |
| Sep 30, 2022 |
49.41% |
| Jun 30, 2022 |
49.91% |
| Mar 31, 2022 |
36.08% |
| Dec 31, 2021 |
33.47% |
| Sep 30, 2021 |
35.76% |
| Jun 30, 2021 |
36.08% |
